Artificial Intelligence is reshaping risk prediction and personalized treatments in hematology. In our new review now published in the British Journal of Haematology, we provide a comprehensive overview of machine learning across leukemias and lymphomas. AI can increasingly decode complex molecular patterns that traditional models miss and moves us closer to truly personalized hematology.
We sincerely thank our amazing colleagues Dr. Wencke Walter and Prof. Dr. med. Dr. phil. Torsten Haferlach from the MLL Münchner Leukämielabor for the once again excellent collaboration!
Read the article here:
